Category: Cardica Inc.
Cardica says it will lay off about 24% of its workforce in a bid to conserve cash as it tries to get its MicroCutter Xchange 30 surgical stapler on the U.S. market.
Cardica (NSDQ:CRDC) this week said it's laying off nearly quarter of its workforce in a bid to conserve cash as it tries to get its MicroCutter Xchange 30 surgical stapler off the ground.
DexCom promotes COO Kevin Sayer to the CEO role and makes former chief executive Terry Gregg its executive chairman.
Cardica shares plunge after it suspends the launch of its MicroCutter Xchange 30 surgical stapler so it can focus on improving the product, a move that may also result in a realignment of its operations.
California surgical devices maker Cardica details a public offering of common and preferred stock aimed at raising $43.9 million to support U.S. sales and marketing efforts.
Cardica unveiled the details of an upcoming public offering of stock, aimed at raising $43.9 million to support commercial efforts for the company's MicroCutter XCHANGE 30 minimally invasive stapling system.
Cardica files for 510(k) clearance from the FDA for its MicroCutter Xchange 30 surgical stapling and cutting device.
Redwood City, Calif.-based Cardica (NSDQ:CRDC) said it filed for 510(k) clearance from the FDA for its surgical device.
Cardica and distribution partner Century Medical submit an application to Japanese regulators for Cardica's MicroCutter Xchange 30 cutting and stapling cartridges.
Cardica (NSDQ:CRDC) and its distribution partner Century Medical are shooting for Japanese regulatory approval for the stapling cartridge components of Cardica's MicroCutter Xchange surgical device.
During its 4th quarter Cardica tacked an additional $300,000 in losses to its bottom line, but managed to beat per-share earnings expectations by 1 cent.
Cardica (NSDQ:CRDC) fell further into the red with a 7% increase in 4th quarter losses compared to the same time last year, as well as an almost 20% increase in losses for the full year.